Introduction：Basic information about CAS 81919-14-4|Bendazac L-lysine, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Bendazac L-lysine |
|---|
| CAS Number | 81919-14-4 | Molecular Weight | 428.482 |
|---|
| Density | / | Boiling Point | 698.4ºC at 760 mmHg |
|---|
| Molecular Formula | C22H28N4O5 | Melting Point | 178-181ºC |
|---|
| MSDS | / | Flash Point | 376.2ºC |
|---|
Names
| Name | Bendazac L-lysine |
|---|
| Synonym | More Synonyms |
|---|
Bendazac L-lysine BiologicalActivity
| Description | Bendazac L-Lysine is one of agents that have been introduced for the management of cataracts, protecting the level of vision in patients, thus delaying the need for surgical intervention. |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Others |
|---|
| References | [1]. Yin XX, et al. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats. |
|---|
Chemical & Physical Properties
| Boiling Point | 698.4ºC at 760 mmHg |
|---|
| Melting Point | 178-181ºC |
|---|
| Molecular Formula | C22H28N4O5 |
|---|
| Molecular Weight | 428.482 |
|---|
| Flash Point | 376.2ºC |
|---|
| Exact Mass | 428.205963 |
|---|
| PSA | 153.69000 |
|---|
| LogP | 3.47590 |
|---|
| InChIKey | OCOCFNMFLNFNIA-ZSCHJXSPSA-N |
|---|
| SMILES | NCCCCC(N)C(=O)O.O=C(O)COc1nn(Cc2ccccc2)c2ccccc12 |
|---|
| Storage condition | 2-8℃ |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- OL5673000
- CHEMICAL NAME :
- L-Lysine, mono(((1-(phenylmethyl)-1H-indazol-3-yl)oxy)acetate), dihydrate
- CAS REGISTRY NUMBER :
- 81919-14-4
- LAST UPDATED :
- 198910
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C16-H14-N2-O3.C6-H14-N2-O2.2H2-O
- MOLECULAR WEIGHT :
- 464.58
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 3100 mg/kg
- TOXIC EFFECTS :
- Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - body temperature decrease
- REFERENCE :
- MDACAP Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1965- Volume(issue)/page/year: 19,649,1983
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 1600 mg/kg
- TOXIC EFFECTS :
- Behavioral - ataxia Lungs, Thorax, or Respiration - dyspnea Nutritional and Gross Metabolic - body temperature decrease
- REFERENCE :
- MDACAP Medicamentos de Actualidad. (J.R. Prous, S.A., Apartado de Correos 540, 08080 Barcelona, Spain) V.1- 1965- Volume(issue)/page/year: 19,649,1983
|
Safety Information
Customs
Synonyms
| L-Lysine-(1-benzyl-1H-indazol-3-yloxy)acetic acid |
| BENDAZAC LYSINE UV |
| L-Lysine, compd. with 2-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]acetic acid (1:1) |
| BENDAZAC L-LYSINE SALT |
| Bendazac lysine |
| Bendazac lysine (ban) |
| L-Lysine, ((1-(phenylmethyl)-1H-indazol-3-yl)oxy)acetate |
| BENDAZAC LYSINE 2H2O |
| Bendalina (tn) |
| (2S)-2,6-Diammoniohexanoate [(1-benzyl-1H-indazol-3-yl)oxy]acetate |
| L-Lysine, mono(((1-(phenylmethyl)-1H-indazol-3-yl)oxy)acetate) |
